Use the text input below to search Topix.net

Visit Venture Capital News

$13.8m in Series B Funding for NovaMed is Led by Fidelity Asia Ventures and Fidelity Biosciences

Posted on January 22, 2008

We are confident that with our unique approach and the valuable guidance of our investment partners, NovaMed will sustain its rapid growth in 2008 and continue to lead and drive development of the specialty pharmaceutical industry in China. The fund was led by the newly involved investors, Fidelity Asia Ventures and its US affiliate, Fidelity Biosciences, with participation from returning investor Atlas Venture. via Venture Capital Access Online ...

Original article link


venture capital